FDA expands use of antibiotic; EC OKs Xtandi; Lyme disease debate grows;

@FierceBiotech: Troubled AstraZeneca models a new industry R&D tie-up as setbacks mount. Story | Follow @FierceBiotech

 @JohnCFierce: Sandoz bulls ahead with full slate of PhIII biosimilar studies. News | Follow @JohnCFierce

@RyanMFierce: PFE shares software for biotech drug research with pharma rivals like GSK, Roche and others. Story | Follow @RyanMFierce

 @EmilyMFierce: Our special ADA 2013 issue, via @RyanMFierce: Here | Follow @EmilyMFierce

> The FDA expanded the approved use of Theravance's ($THRX) antibiotic Vibativ (telavancin) to treat patients with hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) caused by Staphylococcus aureus. Release

> The EC has approved Xtandi for the second-line treatment of prostate cancer. The treatment is marketed by Astellas and Medivation ($MDVN). Story

Medical Device News

 @FierceMedDev: Edwards wins Japanese nod for next-gen Sapien valve. Story | Follow @FierceMedDev

 @DamianFierce: Miss our ADA 2013 coverage? Diabetes news from Medtronic and J&J. | Follow @DamianFierce

 @MichaelGFierce: FDA approved Lombard's Aorflex delivery system, used with its Aorfix stent. Looking to launch this year. More | Follow @MichaelGFierce

> Medtronic leaps toward artificial pancreas with MiniMed study. Story

> J&J's Animas reveals positive artificial pancreas data. Article

Pharma News

 @FiercePharma: CX, that's 7 trials of 5 biosims for Novartis ... Novartis starts PhIII trial of biosimilar of Amgen's Enbrel. Report | Follow @FiercePharma

 @EricPFierce: Has down-home Paula become the 'Deen' of bad publicity for Novo Nordisk? Item | Follow @EricPFierce

 @CarlyHFierce: Shoutout to FierceBiotech in First Manhattan's letter to Vivus shareholders. Letter | Story | Follow @CarlyHFierce

> Russia's Pharmstandard eyes buyers for $2.5B OTC drug business. More

> Proxy challenger scoffs at Vivus as annual meeting nears. Report

> Reported Form 483 may explain Ranbaxy not getting Diovan to market. Story

CRO News

> Icon, Clintec launch grad programs for clinical research. Article

> CRS signs on with Bayer for early trials. Story

> Novotech reaches into Hong Kong, Philippines. News

> inVentiv taps PatientsLikeMe for trial recruitment. Report

Biotech IT News

> Roche designs online software for sequencing business. Story

> FDA taps India's GVK for database support in drug recycling. More

> Pfizer shares software for biotech drug research with pharma rivals. News

> Scientists follow 'Facebook' strategy to corral cancer Big Data. Story

> PatientsLikeMe seals CRO deal for online trial recruitment. Article

And Finally… As new cases of Lyme disease continue to mount, there's a growing argument over the best way to treat it. Story